microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma

Area of Science:

• Dermatology
• Molecular Biology
• Epigenetics

Background:

• Localized scleroderma (LSc) is a fibrotic connective tissue disorder.
• Excessive type I collagen deposition characterizes LSc skin fibrosis.
• Epigenetic factors, including microRNAs (miRNAs), are implicated in collagen dysregulation.

Purpose of the Study:

• To investigate the role of microRNA (miRNA) in the fibrotic mechanisms of localized scleroderma (LSc).
• To identify specific miRNAs involved in collagen overexpression in LSc.
• To evaluate the potential of miRNAs as biomarkers and therapeutic targets for LSc.

Main Methods:

• miRNA expression profiling using PCR arrays and real-time PCR.
• In situ hybridization to localize miRNA expression in skin tissues.
• Functional studies using miRNA inhibitors in cultured fibroblasts.
• Immunoblotting to quantify collagen protein levels.
• Serum miRNA level analysis in LSc patients and healthy controls.

Main Results:

• miR-7 levels were significantly decreased in LSc skin and keloid tissues compared to normal skin.
• In situ hybridization confirmed reduced miR-7 expression in dermal fibroblasts of LSc patients.
• Inhibition of miR-7 in vitro led to increased α2(I) collagen protein expression.
• Serum miR-7 levels were significantly lower in LSc patients than in healthy controls.
• Serum miR-29a levels did not differ between LSc patients and controls.

Conclusions:

• Down-regulation of miR-7, systemically or locally, may contribute to LSc pathogenesis by promoting α2(I) collagen overexpression.
• Serum miR-7 shows potential as a diagnostic biomarker for localized scleroderma.
• Targeting miRNA regulatory mechanisms offers a promising avenue for novel LSc treatments.